Economic Performance: Public Sector

Please see below for information on the following:

Taxes Paid

Bristol-Myers Squibb paid $1,556 million in income taxes in 2007. For more information on taxes paid, refer to the Notes to Consolidated Financial Statements of our Annual Report.

Research and Development

Bristol-Myers Squibb invested approximately $3.3 billion on research and development in 2007. The Company is implementing a new strategy to discover and develop innovative medicines that address areas of significant unmet medical need. These areas include: affective (psychiatric) disorders, Alzheimer’s/dementia, atherosclerosis/thrombosis, diabetes, hepatitis, HIV/AIDS, obesity, oncology, rheumatoid arthritis and related diseases, and solid organ transplant. The Company continuously strives to create better treatments for patients by building a high quality drug discovery and development pipeline.

The Bristol-Myers Squibb Pharmaceutical Research Institute is dedicated to discovering and developing innovative, cost-effective medicines that address significant unmet medical needs that extend and enhance human life. Currently, the Research Institute is developing a number of new compounds, including two potential first-in-class drugs that could represent significant advances in the treatment of HIV/AIDS: an attachment inhibitor and an integrase inhibitor. The attachment inhibitor has advanced to Phase II clinical trials, while the integrase inhibitor is in earlier development.

Political Contributions

Bristol-Myers Squibb works with others to advocate for public policies that encourage the discovery of life-saving and life-enhancing new medicines for patients. We work closely with PhRMA to achieve broad patient access to safe and effective medicines through a free market, without price controls; strong intellectual property incentives; and transparent, efficient regulation and a free flow of information to patients. We are active members of other organizations that support our views on issues affecting the healthcare industry.

Our company believes that we should be an active and effective participant in the political process and should support the legislative process by contributing prudently to state and local candidates and political organizations when such contributions are permitted by federal, state, and local law.

To view a list of all contributions made by Bristol-Myers Squibb Company to individual state candidates, parties, and other organizations eligible to accept corporate contributions and a list of all contributions made by the Bristol-Myers Squibb Employee Political Action Committee ("EPAC"), a multi-candidate Federal PAC connected to Bristol-Myers Squibb Company, use this link.

Last updated June 11, 2008 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.